Polycystic Ovarian Syndrome

被引：97

作者：

Trikudanathan, Subbulaxmi ^{[1
]}

机构：

[1] Univ Washington, Med Ctr, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98105 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2015年 / 99卷 / 01期

关键词：

Polycystic ovarian syndrome; Anovulation; Hyperandrogenism; Insulin resistance; Infertility; Type; 2; diabetes; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; SYNDROME PCOS; WOMEN; PREVALENCE; DIAGNOSIS; METFORMIN; OBESITY; RISK; HYPERANDROGENEMIA;

D O I：

10.1016/j.mcna.2014.09.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Polycystic ovarian syndrome (PCOS) is a complex and phenotypically heterogeneous endocrine disorder that typically presents in reproductiveaged women. Key clinical components include hyperandrogenism, menstrual irregularities, infertility, and cardiometabolic abnormalities. Definition of PCOS has been confusing and controversial because of the lack of consistent diagnostic criteria. Management choices in women with PCOS should target the phenotype and individual needs of the patient. Oral contraceptives remain the first line of treatment for hyperandrogenic symptoms and menstrual dysfunction. Lifestyle modifications and metformin improve metabolic abnormalities. Particular attention should be placed on addressing and preventing the long-term cardiometabolic implications of PCOS.

引用

页码：221 / +

页数：16

共 47 条

[1]

[Anonymous], HUM REPROD

[2] Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].

Apridonidze, T ;

Essah, PA ;

Iuorno, MJ ;

Nestler, JE .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935

[3] Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis [J].

Barry, J. A. ;

Kuczmierczyk, A. R. ;

Hardiman, P. J. .

HUMAN REPRODUCTION, 2011, 26 (09) :2442-2451

[4] Longterm management of Polycystic Ovarian Syndrome (PCOS) [J].

Bates, Gordon W. ;

Legro, Richard S. .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2013, 373 (1-2) :91-97

[5] European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire [J].

Conway, Gerard ;

Dewailly, Didier ;

Diamanti-Kandarakis, Evanthia ;

Escobar-Morreale, Hector F. ;

Franks, Steven ;

Gambineri, Alessandra ;

Kelestimur, Fahrettin ;

Macut, Djuro ;

Micic, Dragan ;

Pasquali, Renato ;

Pfeifer, Marija ;

Pignatelli, Duarte ;

Pugeat, Michel ;

Yildiz, Bulent O. .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 171 (04) :489-498

[6] Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment [J].

DeUgarte, CM ;

Bartolucci, AA ;

Azziz, R .

FERTILITY AND STERILITY, 2005, 83 (05) :1454-1460

[7] Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society [J].

Dewailly, Didier ;

Lujan, Marla E. ;

Carmina, Enrico ;

Cedars, Marcelle I. ;

Laven, Joop ;

Norman, Robert J. ;

Escobar-Morreale, Hector F. .

HUMAN REPRODUCTION UPDATE, 2014, 20 (03) :334-352

[8] Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications [J].

Diamanti-Kandarakis, Evanthia ;

Dunaif, Andrea .

ENDOCRINE REVIEWS, 2012, 33 (06) :981-1030

[9] Screening women with polycystic ovary syndrome for metabolic syndrome [J].

Dokras, A ;

Bochner, M ;

Hollinrake, E ;

Markham, S ;

VanVoorhis, B ;

Jagasia, DH .

OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :131-137

[10] PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].

DUNAIF, A ;

SEGAL, KR ;

FUTTERWEIT, W ;

DOBRJANSKY, A .

DIABETES, 1989, 38 (09) :1165-1174

← 1 2 3 4 5 →